AOL Money & Finance

Analyst downgrades: SNE, FTWR and CRME

More

MOST NOTEWORTHY: Sony, FiberTower and Cardiome Pharma were today's noteworthy downgrades:
  • Goldman lowered its rating on Sony (NYSE: SNE) to Neutral from Buy, citing the yen strength and the economic slowdown.
  • Merriman downgraded shares of FiberTower (NASDAQ: FTWR) to Neutral from Buy following the CEO resignation due to added uncertainty. They do not anticipate the valuation to improve from current levels until a permanent CEO is named.
  • Cardiome Pharma (NASDAQ: CRME) was downgraded to Neutral from Buy at Merrill following the FDA's decision to delay the Kynapid drug.
OTHER DOWNGRADES:
Symbol Lookup
IndexesChangePrice
DJIA+30.6910,464.40
NASDAQ+6.872,176.05
S&P 500+4.981,110.63

Last updated: November 26, 2009: 01:24 PM

BloggingStocks Exclusives

Hot Stocks

DailyFinance Headlines

Latest from BloggingBuyouts

TheFlyOnTheWall.com Headlines

BioHealth Investor Headlines

WalletPop Headlines

My Portfolios

Track your stocks here!

Find out why more people track their portfolios on AOL Money & Finance then anywhere else.

BloggingStocks Partners

More from AOL Money & Finance

WalletPop Headlines